Unmet Needs, Mechanisms of Resistance, and Biomarker Testing in HR+/HER2- Advanced Breast Cancer Progressing on First-line CDK4/6 Inhibitor Plus Endocrine Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
CDK4/6 Inhibitors in the Real World: Evaluating the Evidence in HR-positive/HER2-negative Metastatic Breast Cancer

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00